⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6585698 | 0.81 | — | — | |
| SCHEMBL3408183 | 0.81 | — | — | |
| SCHEMBL11414175 | 0.73 | — | — | |
| SCHEMBL3306317 | 0.72 | — | — | |
| SCHEMBL3403583 | 0.72 | — | — | |
| SCHEMBL14459930 | 0.64 | — | — | |
| SCHEMBL3672691 | 0.61 | — | — | |
| Dimethyl Sulfoxide SCHEMBL28300523 | 0.57 | — | — | |
| SCHEMBL27653823 | 0.57 | — | — | |
| Dimethyl Sulfoxide SCHEMBL27579698 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220403051-A1 | A DOTA binding chimeric antigen receptor for cellular therapy | UNIV PENNSYLVANIA (US) | 2022-12-22 | — | — | US | disclosed |
| US-11053175-B2 | Thioether compounds as nitrification inhibitors | BASF SE (DE) | 2021-07-06 | — | — | US | disclosed |
| WO-2020219715-A1 | A DOTA-BINDING CHIMERIC ANTIGEN RECEPTOR FOR CELLULAR THERAPY | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-10-29 | — | — | WO | disclosed |
| US-20180134633-A1 | THIOETHER COMPOUNDS AS NITRIFICATION INHIBITORS | BASF SE (DE) | 2018-05-17 | — | — | US | disclosed |
| US-20180134633-A1 | THIOETHER COMPOUNDS AS NITRIFICATION INHIBITORS | BASF SE (DE) | 2018-05-17 | — | — | US | disclosed |
| WO-2016180859-A1 | THIOETHER COMPOUNDS AS NITRIFICATION INHIBITORS | BASF SE (DE) | 2016-11-17 | — | — | WO | disclosed |
| EP-1334095-B1 | PROCESS FOR THE PREPARATION OF PGD2 ANTAGONIST | SHIONOGI & CO (JP) | 2005-01-19 | — | — | EP | disclosed |
| EP-1334095-A4 | PROCESS FOR THE PREPARATION OF PGD2 ANTAGONIST | SHIONOGI & CO (JP) | 2004-03-17 | — | — | EP | disclosed |
| US-6693203-B2 | REACTING NOPINONE ENOLATE WITH ALKYL 7-HALO-5-HEPTYNOATE, REACTING PRODUCT WITH HYDROXYLAMINE, TREATING WITH TITANIUM TRICHLORIDE AND BORANE REAGENT, HYDROGENATING, REACTING WITH 5-HYDROXY-4-BENZOTHIOPHENECARBOXYLIC ACID, HYDROLYZING | SHIONOGI & CO., LTD (JP) | 2004-02-17 | — | — | US | disclosed |
| US-20030199702-A1 | Process for the preparation of pgd2 antagonist | LARSEN ROBERT (US) | 2003-10-23 | — | — | US | disclosed |
| EP-1334095-A1 | PROCESS FOR THE PREPARATION OF PGD2 ANTAGONIST | SHIONOGI & CO., LTD. (JP) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002032892-A1 | PROCESS FOR THE PREPARATION OF PGD2 ANTAGONIST | SHIONOGI & CO., LTD (JP) | 2002-04-25 | — | — | WO | disclosed |